Trial Profile

A Phase I Study of the Immune Response to Herpes Simplex Virus Type 1 (HSV-1) and General Immune Health in Subjects Infected With HSV-1

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 11 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Squaric acid dibutylester (Primary)
Indications Herpes simplex virus type 1 infections
Focus Pharmacodynamics; Pharmacogenomic
Sponsors Squarex

Most Recent Events

14 Feb 2019 According to a Squarex media release, clinical data from the study has been published in the peer-reviewed journal Immunity, Inflammation and Disease.
14 Feb 2019 Results presented in a Squarex media release.
17 Sep 2018 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com